(ANSA) - Milan, April 7 - The DiaSorin company has completed
tests at Pavia's Policlinico San Matteo Hospital and the
necessary studies to launch a new high-volume serum test to
detect antibodies in patients infected with COVID-19, it said
Tuesday.
The company said it is working to get the CE label and
authorization for emergency use (EUA) from the Food and Drug
Administration before the end of April.
Italian antibody test by month's end (2)
Necessary tests completed at Pavia hospital says company